Furthermore, the overexpression of MTHFD2 in NSCLC (including adenocarcinoma and squamous cell carcinoma) was also supported by The Cancer Genome Atlas database (Figure 1(d)). This evidence concerns the gene MTHFD2 and squamous cell carcinoma.